Advertisement
Screener

FULGENT GENETICS, INC. (FLGT) EBITDA

FULGENT GENETICS, INC. (FLGT) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$28.40M*; Operating income -$36.07M; Depreciation and amortization $7.68M*.
  • 2026-03-31: Basis Reported; EBITDA -$28.62M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$30.13M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$9.31M*; Operating income -$15.35M; Depreciation and amortization $6.04M*.

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$28.40M*-$36.07M$7.68M*$85.39M-33.26%*$3.86M*-$23.76M*(m)$14.55M(m)$29.00K
2026-03-31Reported-$28.62M(m)(m)(m)-40.23%$5.20M$7.10M(m)$14.18M(m)-$704.00K
2025-12-31Reported-$30.13M(m)(m)(m)-36.15%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$9.31M*-$15.35M$6.04M*$84.07M-11.08%*$6.05M*$11.11M*(m)$13.86M(m)-$683.00K
2025-06-30Reported-$13.66M*-$19.71M$6.05M*$81.80M-16.70%*$6.83M*-$30.17M*(m)$13.48M(m)-$2.26M
2025-03-31Reported-$13.88M(m)(m)(m)-18.89%$4.72M-$4.43M(m)$12.39M(m)$176.00K
2024-12-31Reported-$9.94M(m)(m)(m)-13.05%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$11.16M(m)(m)(m)-15.55%$19.54M*-$15.51M*(m)$11.78M(m)-$3.84M
2024-06-30Reported-$12.75M(m)(m)(m)-17.95%$12.94M*$4.29M*(m)$13.49M(m)-$2.12M
2024-03-31Reported-$15.14M(m)(m)(m)-23.47%$4.06M$7.27M(m)$11.43M(m)-$327.00K
2023-12-31Reported-$144.59M(m)(m)(m)-205.07%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$6.63M(m)(m)(m)7.83%$4.92M*$10.24M*(m)$10.01M(m)$20.33M
2023-06-30Reported-$13.49M(m)(m)(m)-19.88%$12.14M*$9.74M*(m)$9.69M(m)-$3.11M
2023-03-31Reported-$17.95M(m)(m)(m)-27.12%$2.03M-$7.91M(m)$9.78M(m)-$5.20M
2022-12-31Reported-$26.75M(m)(m)(m)-39.51%(m)(m)(m)$8.51M(m)-$9.39M
2022-09-30Reported$10.17M*$352.00K$9.82M*$105.66M9.63%*$5.43M*$20.78M*(m)$7.51M(m)$414.00K
2022-06-30Reported$21.14M*$12.79M$8.35M*$125.34M16.87%*$3.26M*$11.13M*(m)$6.91M(m)$2.65M
2022-03-31Reported$206.63M(m)(m)(m)64.52%$5.36M$188.41M(m)$5.99M(m)$48.42M
2021-12-31Reported$154.35M(m)(m)(m)61.33%(m)(m)(m)$7.46M(m)$47.15M
2021-09-30Reported$162.45M*$159.27M$3.17M*$227.87M71.29%*$3.40M*$152.20M*(m)$6.02M(m)$37.55M
2021-06-30Reported$101.32M*$98.90M$2.42M*$153.62M65.95%*$2.94M*$76.11M*(m)$5.31M(m)$23.59M
2021-03-31Reported$268.84M(m)(m)(m)74.80%$11.49M$233.18M(m)$5.42M(m)$66.51M
2020-12-31Reported$227.03M(m)(m)(m)76.97%(m)(m)(m)$4.58M(m)$58.57M
2020-09-30Reported$64.25M*$63.52M$722.00K*$101.72M63.16%*$10.13M*$9.41M*(m)$3.18M(m)$14.53M
2020-06-30Reported(m)$2.64M(m)$17.27M(m)$411.00K*-$4.41M*(m)$1.85M(m)-$599.00K
2020-03-31Reported(m)-$1.91M(m)$7.75M(m)$796.00K$1.37M(m)$1.98M(m)$34.00K
2019-12-31Reported(m)-$409.00K(m)$8.39M(m)(m)(m)(m)$1.79M(m)-$38.00K
2019-09-30Reported(m)$1.51M(m)$10.35M(m)$88.00K*$3.90M*(m)$1.74M(m)$61.00K
2019-06-30Reported(m)$295.00K(m)$8.42M(m)$499.00K*$675.00K*(m)$1.57M(m)$7.00K
2019-03-31Reported(m)-$1.82M(m)$5.37M(m)$134.00K$1.05M(m)$1.42M(m)$13.00K
2018-12-31Reported(m)-$1.03M(m)$5.67M(m)(m)(m)(m)$1.43M(m)$888.00K
2018-09-30Reported(m)-$846.00K(m)$5.63M(m)$1.05M*-$105.00K*(m)$1.44M(m)-$318.00K
2018-06-30Reported(m)-$1.00M(m)$5.40M(m)$36.00K*-$57.00K*(m)$1.21M(m)-$100.00K
2018-03-31Reported(m)-$2.19M(m)$4.65M(m)$1.12M-$1.29M(m)$1.46M(m)-$434.00K
2017-12-31Reported(m)-$2.07M(m)$4.28M(m)(m)(m)(m)$1.32M(m)-$596.00K
2017-09-30Reported(m)-$1.48M(m)$4.50M(m)$237.00K*$500.00K*(m)$1.13M(m)-$415.00K
2017-06-30Reported(m)-$150.00K(m)$4.64M(m)$1.43M*$564.00K*(m)$920.00K(m)-$110.00K
2017-03-31Reported(m)$219.00K(m)$5.31M(m)$90.00K$1.51M(m)$851.00K(m)$106.00K
2016-12-31Reported(m)$1.26M(m)(m)(m)(m)(m)(m)$818.00K(m)$503.00K
2016-09-30Reported(m)-$695.00K(m)(m)(m)$2.82M*$798.00K*(m)$1.52M(m)$417.00K
2016-06-30Reported(m)$970.00K(m)(m)(m)$386.00K*$1.48M*(m)$656.00K(m)$0.00
2016-03-31Reported(m)-$615.00K(m)(m)(m)$177.00K$875.00K(m)$561.00K(m)$0.00
2015-12-31Reported(m)-$7.34M(m)(m)(m)(m)(m)(m)$3.65M(m)(m)
2015-09-30Reported(m)$1.18M(m)(m)(m)(m)(m)(m)$312.00K(m)$0.00
2015-06-30Reported(m)$747.00K(m)(m)(m)(m)(m)(m)$252.00K(m)(m)
2015-03-31Reported(m)$405.00K(m)(m)(m)(m)(m)(m)$217.00K(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$66.97M(m)(m)(m)-20.76%$22.57M-$101.64M(m)$53.91M(m)-$8.39M
2024-12-31Reported-$48.99M(m)(m)(m)-17.28%$40.31M$21.06M(m)$48.82M(m)-$8.14M
2023-12-31Reported-$169.39M(m)(m)(m)-58.57%$22.21M$27.00M(m)$41.44M(m)$1.15M
2023-09-30Rolling(m)-$80.96M*(m)$286.41M*(m)(m)(m)(m)$38.00M*(m)$2.63M*
2023-06-30Rolling(m)-$80.82M*(m)$307.38M*(m)(m)(m)(m)$35.49M*(m)-$17.28M*
2023-03-31Rolling(m)-$48.23M*(m)$364.87M*(m)(m)(m)(m)$32.70M*(m)-$11.52M*
2022-12-31Reported$211.19M(m)(m)(m)34.12%$18.77M$253.52M(m)$28.91M(m)$42.10M
2022-12-31Rolling(m)$178.53M*(m)$618.97M*(m)(m)(m)(m)$28.91M*(m)$42.10M*
2022-09-30Rolling(m)$365.94M*(m)$802.93M*(m)(m)(m)(m)$27.86M*(m)$98.64M*
2022-06-30Rolling(m)$524.86M*(m)$925.15M*(m)(m)(m)(m)$26.38M*(m)$135.77M*
2022-03-31Rolling(m)$610.96M*(m)$953.42M*(m)(m)(m)(m)$24.79M*(m)$156.70M*
2021-12-31Reported$686.96M(m)(m)(m)69.21%$23.81M$538.58M(m)$24.22M(m)$174.79M
2021-12-31Rolling(m)$675.95M*(m)$992.58M*(m)(m)(m)(m)$24.22M*(m)$174.79M*
2021-09-30Rolling(m)$751.00M*(m)$1.04B*(m)(m)(m)(m)$21.33M*(m)$186.22M*
2021-06-30Rolling(m)$655.25M*(m)$909.74M*(m)(m)(m)(m)$18.49M*(m)$163.20M*
2021-03-31Rolling(m)$558.99M*(m)$773.39M*(m)(m)(m)(m)$15.02M*(m)$139.01M*
2020-12-31Reported$293.12M(m)(m)(m)69.51%$35.13M$140.63M(m)$11.58M(m)$72.53M
2020-12-31Rolling(m)$290.16M*(m)$421.71M*(m)(m)(m)(m)$11.58M*(m)$72.53M*
2020-09-30Rolling(m)$63.84M*(m)$135.12M*(m)(m)(m)(m)$8.80M*(m)$13.92M*
2020-06-30Rolling(m)$1.83M*(m)$43.75M*(m)(m)(m)(m)$7.37M*(m)-$542.00K*
2020-03-31Rolling(m)-$519.00K*(m)$34.91M*(m)(m)(m)(m)$7.09M*(m)$64.00K*
2019-12-31Reported$1.68M(m)(m)(m)5.16%$1.18M$5.52M$0.00$6.54M(m)$43.00K
2019-12-31Rolling(m)-$428.00K*(m)$32.53M*(m)(m)(m)(m)$6.54M*(m)$43.00K*
2019-09-30Rolling(m)-$1.05M*(m)$29.81M*(m)(m)(m)(m)$6.17M*(m)$969.00K*
2019-06-30Rolling(m)-$3.40M*(m)$25.09M*(m)(m)(m)(m)$5.86M*(m)$590.00K*
2019-03-31Rolling(m)-$4.70M*(m)$22.07M*(m)(m)(m)(m)$5.50M*(m)$483.00K*
2018-12-31Reported(m)-$5.07M(m)$21.35M(m)$2.32M-$675.00K$0.00$5.53M(m)$36.00K
2018-12-31Rolling(m)-$5.07M*(m)$21.35M*(m)(m)(m)(m)$5.53M*(m)$36.00K*
2018-09-30Rolling(m)-$6.11M*(m)$19.96M*(m)(m)(m)(m)$5.43M*(m)-$1.45M*
2018-06-30Rolling(m)-$6.75M*(m)$18.84M*(m)(m)(m)(m)$5.12M*(m)-$1.54M*
2018-03-31Rolling(m)-$5.89M*(m)$18.08M*(m)(m)(m)(m)$4.83M*(m)-$1.55M*
2017-12-31Reported(m)-$3.48M(m)$18.73M(m)$2.90M$1.33M(m)$4.22M(m)-$1.01M
2017-12-31Rolling(m)-$3.48M*(m)$18.73M*(m)(m)(m)(m)$4.22M*(m)-$1.01M*
2017-09-30Rolling(m)-$153.00K*(m)(m)(m)(m)(m)(m)$3.72M*(m)$84.00K*
2017-06-30Rolling(m)$633.00K*(m)(m)(m)(m)(m)(m)$4.11M*(m)$916.00K*
2017-03-31Rolling(m)$1.75M*(m)(m)(m)(m)(m)(m)$3.85M*(m)$1.03M*
2016-12-31Reported(m)$918.00K(m)(m)(m)$3.79M$4.41M(m)$3.56M(m)$920.00K
2016-12-31Rolling(m)$919.00K*(m)(m)(m)(m)(m)(m)$3.56M*(m)$920.00K*
2016-09-30Rolling(m)-$7.68M*(m)(m)(m)(m)(m)(m)$6.39M*(m)(m)
2016-06-30Rolling(m)-$5.81M*(m)(m)(m)(m)(m)(m)$5.18M*(m)(m)
2016-03-31Rolling(m)-$6.03M*(m)(m)(m)(m)(m)(m)$4.78M*(m)(m)
2015-12-31Reported(m)-$5.01M(m)(m)(m)$2.10M-$969.00K(m)$4.43M(m)$0.00
2015-12-31Rolling(m)-$5.01M*(m)(m)(m)(m)(m)(m)$4.43M*(m)(m)
2014-12-31Reported(m)-$990.00K(m)(m)(m)$731.00K-$4.40M(m)$521.00K(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIODESIX INC (BDSX)United States$0.312B
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B